FOLLISTIM Side Effects

6916575-4 | Ovarian Haemorrhage
on Aug 03, 2010 Female patient from JAPAN , 36 years of age, weighting 90.39 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian haemorrhage. Follistim dosage: 225 Iu;sc. During the same period patient was treated with SUPRECUR (View Suprecur Review and Suprecur Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), CHORIONIC GONADOTROPIN (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ). Patient was hospitalized.

6915319-X | Dehydration, Ovarian Hyperstimulation Syndrome, Palpitations, Ventricular Extrasystoles, Weight Increased
Patient was taking Follistim (View Usage). Patient had the following side effects: dehydration, ovarian hyperstimulation syndrome, palpitations, ventricular extrasystoles, weight increased on Aug 06, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with infertility (What is infertility?) and. Follistim dosage: 300 Iu 1 X/day Sq. During the same period patient was treated with OVIDREL (250 Micrograms 1 Sq) (View Ovidrel Review and Ovidrel Label ).

6811948-2 | Abortion Threatened, Caesarean Section, Pregnancy, Threatened Labour
Adverse event was reported on Jun 25, 2010 by a Female patient taking Follistim (View Usage) (Dosage: 150 Iu; ; Im) was diagnosed with in vitro fertilisation and. Location: JAPAN , 37 years of age, weighting 105.8 lb, After Follistim was administered, patient had the following side effects: abortion threatened, caesarean section, pregnancy (What is pregnancy?), threatened labour. During the same period patient was treated with NORGESTREL AND ETHINYL ESTRADIOL (View Norgestrel And Ethinyl Estradiol Review and Norgestrel And Ethinyl Estradiol Label ), CLOMID (View Clomid Review and Clomid Label ), DUPHASTON (View Duphaston Review and Duphaston Label ), JUVELA N (View Juvela N Review and Juvela N Label ), PROGESTERON (View Progesteron Review and Progesteron Label ). Patient was hospitalized.

6800720-5 | Pneumomediastinum, Respiratory Disorder Neonatal
on Jun 18, 2010 Female patient from JAPAN , weighting 7.23 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). Patient experienced the following unwanted or unexpected effects: pneumomediastinum, respiratory disorder neonatal. Follistim dosage: .


6799502-2 | Caesarean Section, Hypoglycaemia Neonatal, Maternal Condition Affecting Foetus
on Jun 18, 2010 Male patient from JAPAN , weighting 7.23 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). Patient had the following side effects: caesarean section, hypoglycaemia neonatal, maternal condition affecting foetus. Follistim dosage: .

6769113-3 | Caesarean Section, Ovarian Hyperstimulation Syndrome, Placenta Praevia, Premature Labour
Patient was taking Follistim (View Usage). After Follistim was administered, patient had the following side effects: caesarean section, ovarian hyperstimulation syndrome, placenta praevia, premature labour on May 28, 2010 from JAPAN Additional patient health information: Female patient , 35 years of age, weighting 123.5 lb, was diagnosed with in vitro fertilisation and. Follistim dosage: 225 Iu; Qd; Sc, 150 Iu; Qd; Sc. During the same period patient was treated with DUOLUTON /00948701/ (View Duoluton /00948701/ Review and Duoluton /00948701/ Label ), BUSERECUR (View Buserecur Review and Buserecur Label ), CHORIONIC GONADOTROPIN (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), PROGEHORMON (View Progehormon Review and Progehormon Label ). Patient was hospitalized.

6758732-6 | Pregnancy, Premature Labour
Adverse event was reported on May 28, 2010 by a Female patient taking Follistim (View Usage) (Dosage: 225 Iu;qd;sc; 150 Iu;qd;sc) was diagnosed with in vitro fertilisation and. Location: JAPAN , 32 years of age, weighting 101.4 lb, Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?), premature labour. During the same period patient was treated with DUOLUTON /00948702/ (CON.) (View Duoluton /00948702/ (con.) Review and Duoluton /00948702/ (con.) Label ), CETROTIDE (CON.) (View Cetrotide (con.) Review and Cetrotide (con.) Label ), HCG (CON.) (View Hcg (con.) Review and Hcg (con.) Label ), ESTRADERM M (CON.) (View Estraderm M (con.) Review and Estraderm M (con.) Label ), PROGESTERONE (CON.) (View Progesterone (con.) Review and Progesterone (con.) Label ). Patient was hospitalized.

6758716-8 | Caesarean Section, Respiratory Disorder Neonatal
on May 28, 2010 Male patient from JAPAN , weighting 5.45 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). Patient had the following side effects: caesarean section, respiratory disorder neonatal. Follistim dosage: . Patient was hospitalized.

6754990-2 | Caesarean Section, Placenta Praevia, Pregnancy, Small For Dates Baby
on May 28, 2010 Female patient from JAPAN , 33 years of age, weighting 97.00 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). After Follistim was administered, patient had the following side effects: caesarean section, placenta praevia, pregnancy (What is pregnancy?), small for dates baby. Follistim dosage: 150 Iu; Qd; Sc. During the same period patient was treated with BUSERECUR (View Buserecur Review and Buserecur Label ), DUOLUTION (View Duolution Review and Duolution Label ), CHORIONIC GONADOTROPIN (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), LUTORAL (View Lutoral Review and Lutoral Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), PROGE DEPOT (View Proge Depot Review and Proge Depot Label ), PELANIN (View Pelanin Review and Pelanin Label ). Patient was hospitalized.

6754988-4 | Caesarean Section, Premature Labour, Premature Rupture Of Membranes
Patient was taking Follistim (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, premature labour, premature rupture of membranes on May 28, 2010 from JAPAN Additional patient health information: Female patient , 35 years of age, weighting 136.7 lb, was diagnosed with in vitro fertilisation and. Follistim dosage: 150 Iu;qd;sc. During the same period patient was treated with NORETHISTERONE (View Norethisterone Review and Norethisterone Label ), BUSERECUR (View Buserecur Review and Buserecur Label ), CHORIONIC GONADOTROPIN (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), ESTRANA (View Estrana Review and Estrana Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), GLYCORAN (View Glycoran Review and Glycoran Label ). Patient was hospitalized.

6736458-2 | Pneumomediastinum
Adverse event was reported on May 10, 2010 by a Female patient taking Follistim (View Usage) (Dosage: ) was diagnosed with in vitro fertilisation and. Location: JAPAN , weighting 7.23 lb, Patient had the following side effects: pneumomediastinum.

6736457-0 | Caesarean Section, Hypoglycaemia Neonatal
on May 10, 2010 Male patient from JAPAN , weighting 7.23 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). After Follistim was administered, patient had the following side effects: caesarean section, hypoglycaemia neonatal. Follistim dosage: .

6732618-5 | Abortion Threatened, Caesarean Section, Threatened Labour
on May 10, 2010 Female patient from JAPAN , 37 years of age, weighting 105.8 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). Patient experienced the following unwanted or unexpected effects: abortion threatened, caesarean section, threatened labour. Follistim dosage: 150 Iu; ;im. During the same period patient was treated with NORGESTREL AND ETHINYL ESTRADIOL (View Norgestrel And Ethinyl Estradiol Review and Norgestrel And Ethinyl Estradiol Label ), CLOMID (View Clomid Review and Clomid Label ), DUPHASTON (View Duphaston Review and Duphaston Label ), JUVELA N (View Juvela N Review and Juvela N Label ), PROGESTERON (View Progesteron Review and Progesteron Label ). Patient was hospitalized.

6729736-4 | Ovarian Haemorrhage
Patient was taking Follistim (View Usage). Patient had the following side effects: ovarian haemorrhage on May 10, 2010 from JAPAN Additional patient health information: Female patient , 36 years of age, weighting 90.39 lb, was diagnosed with in vitro fertilisation and. Follistim dosage: 225 Iu; Sc. During the same period patient was treated with SUPRECUR (View Suprecur Review and Suprecur Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), CHORIONIC GONADOTROPIN (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ). Patient was hospitalized.

6642713-7 | Abortion Threatened, Caesarean Section, Pregnancy, Threatened Labour
Adverse event was reported on Mar 09, 2010 by a Female patient taking Follistim (View Usage) (Dosage: 150 Iu; Im; 150 Iu; Im; 150 Iu; Im) was diagnosed with in vitro fertilisation and. Location: JAPAN , 37 years of age, weighting 105.8 lb, After Follistim was administered, patient had the following side effects: abortion threatened, caesarean section, pregnancy (What is pregnancy?), threatened labour. During the same period patient was treated with PLANOVAR (CON.) (View Planovar (con.) Review and Planovar (con.) Label ), CLOMID (CON.) (View Clomid (con.) Review and Clomid (con.) Label ), DUPHASTON (CON.) (View Duphaston (con.) Review and Duphaston (con.) Label ), JUVELA N (CON.) (View Juvela N (con.) Review and Juvela N (con.) Label ), PROGESTERON (CON.) (View Progesteron (con.) Review and Progesteron (con.) Label ). Patient was hospitalized.

6583634-8 | Caesarean Section, Ovarian Hyperstimulation Syndrome, Placenta Praevia, Pregnancy
on Jan 22, 2010 Female patient from JAPAN , 35 years of age, weighting 123.5 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, ovarian hyperstimulation syndrome, placenta praevia, pregnancy (What is pregnancy?). Follistim dosage: 225 Iu;qd;sc ; 150 Iu;qd;sc. During the same period patient was treated with DUOLUTON /00948701/ (View Duoluton /00948701/ Review and Duoluton /00948701/ Label ), BUSERECUR (View Buserecur Review and Buserecur Label ), CHORIONIC GONADOTROPIN (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), PROGEHORMON (View Progehormon Review and Progehormon Label ). Patient was hospitalized.

6568926-0 | Caesarean Section, Respiratory Disorder Neonatal
on Jan 22, 2010 Male patient from JAPAN , weighting 5.45 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). Patient had the following side effects: caesarean section, respiratory disorder neonatal. Follistim dosage: . Patient was hospitalized.

6568910-7 | Caesarean Section, Placenta Praevia, Pregnancy
Patient was taking Follistim (View Usage). After Follistim was administered, patient had the following side effects: caesarean section, placenta praevia, pregnancy (What is pregnancy?) on Jan 22, 2010 from JAPAN Additional patient health information: Female patient , 33 years of age, weighting 97.00 lb, was diagnosed with in vitro fertilisation and. Follistim dosage: 150 Iu;qd;sc. During the same period patient was treated with DUOLUTON /00948701/ (CON.) (View Duoluton /00948701/ (con.) Review and Duoluton /00948701/ (con.) Label ), BUSERECUR (CON.) (View Buserecur (con.) Review and Buserecur (con.) Label ), HCG (CON.) (View Hcg (con.) Review and Hcg (con.) Label ), LUTORAL (CON.) (View Lutoral (con.) Review and Lutoral (con.) Label ), BUFFERIN (CON.) (View Bufferin (con.) Review and Bufferin (con.) Label ), PROGE DEPOT (CON.) (View Proge Depot (con.) Review and Proge Depot (con.) Label ), PELANIN (CON.) (View Pelanin (con.) Review and Pelanin (con.) Label ). Patient was hospitalized.

6568795-9 | Pregnancy, Premature Rupture Of Membranes
Adverse event was reported on Jan 22, 2010 by a Female patient taking Follistim (View Usage) (Dosage: 150 Iu;qd;sc) was diagnosed with in vitro fertilisation and. Location: JAPAN , 35 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?), premature rupture of membranes. During the same period patient was treated with NORETHISTERONE (View Norethisterone Review and Norethisterone Label ), BUSERECUR (View Buserecur Review and Buserecur Label ), CHORIONIC GONADOTROPIN (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), ESTRANA (View Estrana Review and Estrana Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), GLYCORAN (View Glycoran Review and Glycoran Label ). Patient was hospitalized.

6568788-1 | Pregnancy, Premature Labour
on Jan 22, 2010 Female patient from JAPAN , 32 years of age, weighting 101.4 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). Patient had the following side effects: pregnancy (What is pregnancy?), premature labour. Follistim dosage: 225 Iu; Qd; Sc, 150 Iu; Qd; Sc. During the same period patient was treated with DUOLUTION (View Duolution Review and Duolution Label ), CETROTIDE (View Cetrotide Review and Cetrotide Label ), CHORIONIC GONADOTROPIN (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ). Patient was hospitalized.

6523140-X | Abortion Spontaneous, Antibody Test Positive, Antiphospholipid Syndrome, Cardiolipin Antibody Positive, Pregnancy
on Dec 17, 2009 Female patient from JAPAN , 36 years of age, weighting 112.4 lb, was diagnosed with in vitro fertilisation and was treated with Follistim (View Usage). After Follistim was administered, patient had the following side effects: abortion spontaneous, antibody test positive, antiphospholipid syndrome, cardiolipin antibody positive, pregnancy (What is pregnancy?). Follistim dosage: 150 Iu, Im. During the same period patient was treated with SUPRECUR (View Suprecur Review and Suprecur Label ), HMG FUJI SEIYAKU (View Hmg Fuji Seiyaku Review and Hmg Fuji Seiyaku Label ), PROFASI HP (View Profasi Hp Review and Profasi Hp Label ), NORGESTREL AND ETHINYL ESTRADIOL (View Norgestrel And Ethinyl Estradiol Review and Norgestrel And Ethinyl Estradiol Label ), PROGESTON FUJI (View Progeston Fuji Review and Progeston Fuji Label ), GONATROPIN (View Gonatropin Review and Gonatropin Label ), PROGE DEPOT (View Proge Depot Review and Proge Depot Label ). Patient was hospitalized.

6454773-7 | Breech Presentation, Caesarean Section, Ovarian Hyperstimulation Syndrome, Pregnancy, Premature Rupture Of Membranes
Patient was taking Follistim (View Usage). Patient experienced the following unwanted or unexpected effects: breech presentation, caesarean section, ovarian hyperstimulation syndrome, pregnancy (What is pregnancy?), premature rupture of membranes on Aug 25, 2009 from JAPAN Additional patient health information: Female patient , 28 years of age, weighting 116.8 lb, was diagnosed with ovulation induction and. Follistim dosage: 150 Iu, Qd, Sc. During the same period patient was treated with CHORIONIC GONADOTROPIN (6000 Iu, Once;) (View Chorionic Gonadotropin Review and Chorionic Gonadotropin Label ), SUPECUR (View Supecur Review and Supecur Label ), HYDROXYPROGESTERONE CAPROATE (View Hydroxyprogesterone Caproate Review and Hydroxyprogesterone Caproate Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), LUTORAL (View Lutoral Review and Lutoral Label ).

6454772-5 | Abortion Spontaneous, Antiphospholipid Syndrome
Adverse event was reported on Aug 31, 2009 by a Female patient taking Follistim (View Usage) (Dosage: 150 Iu; Im) was diagnosed with in vitro fertilisation and. Location: JAPAN , 36 years of age, weighting 112.4 lb, Patient had the following side effects: abortion spontaneous, antiphospholipid syndrome. During the same period patient was treated with SUPRECUR (View Suprecur Review and Suprecur Label ), HMG FUJI SEIYAKU (View Hmg Fuji Seiyaku Review and Hmg Fuji Seiyaku Label ), PROFASI HP (View Profasi Hp Review and Profasi Hp Label ), NORGESTREL AND ETHINYL ESTRADIOL (View Norgestrel And Ethinyl Estradiol Review and Norgestrel And Ethinyl Estradiol Label ), PROGESTON FUJI (View Progeston Fuji Review and Progeston Fuji Label ), GONATROPIN (View Gonatropin Review and Gonatropin Label ), PROGE DEPOT (View Proge Depot Review and Proge Depot Label ). Patient was hospitalized.

5565908-2 | Colitis Ulcerative, Rectal Tenesmus
on Nov 30, 2007 Female patient from DENMARK , 36 years of age, was diagnosed with ovarian hyperstimulation syndrome and was treated with Follistim (View Usage). After Follistim was administered, patient had the following side effects: colitis ulcerative, rectal tenesmus. Follistim dosage: 200 Iu Subcutaneous. During the same period patient was treated with MARVELON (View Marvelon Review and Marvelon Label ), GANIRELIX ACETATE INJECTION (View Ganirelix Acetate Injection Review and Ganirelix Acetate Injection Label ), CHORIONIC GONADOTROPHIN (View Chorionic Gonadotrophin Review and Chorionic Gonadotrophin Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ). Patient was hospitalized.

5355795-X | Coagulopathy, Contusion
on Jun 11, 2007 Female patient from UNITED STATES , 27 years of age, weighting 130.0 lb, was diagnosed with infertility (What is infertility?) and was treated with Follistim (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, contusion. Follistim dosage: 50iu Once Daily Im.

5279926-5 | Punctate Keratitis
Patient was taking Follistim (View Usage). Patient had the following side effects: punctate keratitis on Mar 27, 2007 from UNITED STATES Additional patient health information: Female patient , 41 years of age, weighting 160.0 lb, was diagnosed with infertility female, pregnancy (What is pregnancy?) and. Follistim dosage: 150 Units Daily Days 2 -12 Sq. During the same period patient was treated with GANARELIX 250MICROGM/0.5ML ORGANON USA (250 Daily Days 11-12 Sq) (View Ganarelix 250microgm/0.5ml Organon Usa Review and Ganarelix 250microgm/0.5ml Organon Usa Label ).

4893294-X | Dyspnoea
Adverse event was reported on Jan 25, 2006 by a Female patient taking Follistim (View Usage) (Dosage: 125 Iv For 5d Qd X 7 Days Sq; 150 Iv For 2 D) was diagnosed with infertility (What is infertility?) and. Location: UNITED STATES , weighting 175.0 lb, After Follistim was administered, patient had the following side effects: dyspnoea.